Beam Therapeutics Inc. (BEAM) NASDAQ

18.29

+1.04(+6.03%)

Updated at May 09 10:15AM

Currency In USD

Valuation

Market Cap2.04B
Enterprise Value1.92B
P/E Ratio-3.79
PEG Ratio0.02
Price/Sales Ratio27.31
Price/Book Ratio1.95
Enterprise/Revenue25.41
Enterprise/EBITDA-4.2

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-5.93
Operating Margin-6.54

Management Effectiveness

Return On Assets-0.34
Return On Equity-0.46

Income Statement

Revenue63.52M
Revenue/Share0.77
Gross Profit41.59M
EBITDA-383.98M
Net Income-376.74M
Diluted EPS-4.58

Balance Sheet

Total Cash850.74M
Total Cash/Share10.27
Total Debt161.43M
Total Debt/Equity0.22
Current Ratio4.82
Book Value Per Share8.86

Price History

52-Week Change-23.47
52-Week High35.25
52-Week Low13.53
Moving Average 50 Days21.08
Moving Average 200 Days24.86

Statistics

Average Volume2.37M
Shares Outstanding100.56M
% Held by Institutions98.87

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A